Publishes research papers of broad general interest and biological significance in the areas of molecular biology, molecular genetics, and related fields. Uses two research formats; research papers and short research communications, in addition to review articles and perspectives. Topics include molecular genetics, human disease, cancer research, neurobiology, developmental and plant biology. Covers aspects of the life sciences and provides answers to the most actively investigated questions. Media Kit: http://genesdev.cshlp.org/site/misc/2012_Media_Kit.pdf

Dedicated to functional genetics of the immune response. Emphasizes studies which demonstrate genetic, genomic or functional variation in the immune system, and assists in the understanding of how the basic control over the immune system varies between individuals both in health and disease.

Geneseo Republic is a weekly newspaper providing news and information for Geneseo, IL. The advertising deadline is noon CT on Wednesdays.

Geneseo Republic is a weekly newspaper providing news and information for Geneseo, IL.

Established in 1981 and written for biotech and biopharma professionals involved in research, technical and commercial management. Provides coverage of biotechnology news and developments, scale-up and bioprocess technologies, regulatory and legal issues, new products and R&D and novel drug discovery techniques. Also includes financial news (public offerings, mergers and venture capital investments), funding and government news, corporate profiles, university news, meeting reports, international round-ups and literature information and articles relating to research projects and the production of biotechnology products.Regular topics in the publication include drug discovery technologies and R&D, trends in instrumentation, genomics and downstream omics, gene therapy, industrial biotechnology, enzymes, bioprocessing strategies, contract manufacture, monoclonal antibodies, bioinformatics, cell culture, LIMS, business issues and regulatory issues.Features the channels: Biobusiness which covers financial, business or patent related; Drug Discovery handles technical issues related to early stages of research and finding new pharmaceuticals; Omics spotlights genomics, proteomics and technologies such as metabolomics and Translational Medicine focuses on clinical and scientific efforts that concerns research and clinical settings. Other sections: Podcasts; Blogs; New Products; Best of the Web; GEN Updates RNAi; Oligonucleotides; Next-Generation Sequencing; Jobs; Classified Mart Marketplace; Real Estate; Conferences/Meetings; and Biotech Companies.The site offers RSS (Really Simple Syndication) and a digital Podcast.The publication DOES accept article submissions. Articles should be submitted to Managing Editor. Articles can be submitted either as POV articles, tutorials, overviews for the Transitional Medicine section, or online. For POV articles, they should be submitted one to two months in advance and should be about 1000 words. For tutorials, the articles should be submitted 4-6 months in advance and should be 1000-12000 words. For the Transitional Medicine section, these articles should be overviews, as opposed to specific points of view. They should also be 1000 words. For the online perspectives, they should be submitted a week before.

Intended for scientists and engineers working in bioproduct research, development and bioprocess. Provides coverage of biotechnology news and developments, scale-up and bioprocess technologies, regulatory and legal issues and R&D and novel drug discovery techniques. Also includes financial news (public offerings, mergers and venture capital investments), funding and government news, corporate profiles, university news, meeting reports, international round-ups, new products and literature information, and articles relating to research projects and the production of biotechnology products.

Genetic Literacy Project covers News and other topics

Formerly called Genetic Testing and written for medical researchers specializing in genetics testing. Covers all aspects of genetic testing including prenatal diagnosis, risk assessment, clinical consequences of molecular genetics, results of population screens and targeted testing, methodologies, strategies and ethical and legal issues

NewsRX™ is a digital news, publishing technology and IT company and uses an automated article writing and periodical production software platform (Artificial Intelligence Journalist – AIJ) producing 35,000 unique articles weekly and 195 autocreated digital newsweeklies. Artificial Intelligence Journalist™ (“AIJ”) and Artificial Intelligence Editor™ (“AIE”), is a proprietary software technology which automates every aspect of publishing, from writing and editing to distribution and analytics.

Genetics in Medicine (GIM) is an official journal of the American College of Medical Genetics and Genomics. The journal's mission is to enhance the knowledge, understanding, and practice of medical genetics and genomics through publications in clinical and laboratory genetics and genomics, including ethical, legal, and social issues as well as public health. As genetics and genomics continue to increase in importance and relevance in medical practice, the journal will be an accessible and authoritative resource for the dissemination of medical genetic knowledge to all medical providers through appropriate original research, reviews, commentaries, standards, and guidelines. GIM encourages research that combats racism, includes diverse populations and is written by authors from diverse and underrepresented backgrounds.Genetics in Medicine (GIM) is an official journal of the American College of Medical Genetics and Genomics. The journal's mission is to enhance the knowledge, understanding, and practice of medical genetics and genomics through publications in clinical and laboratory genetics and genomics, including ethical, legal, and social issues as well as public health. As genetics and genomics continue to increase in importance and relevance in medical practice, the journal will be an accessible and authoritative resource for the dissemination of medical genetic knowledge to all medical providers through appropriate original research, reviews, commentaries, standards, and guidelines. GIM encourages research that combats racism, includes diverse populations and is written by authors from diverse and underrepresented backgrounds.